Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia
Clinical trial NCT02724917 · SUSPENDED
Trial details
- NCT number
- NCT02724917
- Sponsor
- CoMentis
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.